We advocate for the further evaluation of plasma MMP-8 as a biomarker of culture positivity to support tuberculosis treatment monitoring as a triage test, with the aim of early identification of treatment failure and appropriate allocation of diagnostic resources, to better support care of patients and improve tuberculosis treatment outcomes. The gene discussed is MMP8; the disease is tuberculosis.